收藏切换
Clinical observation of thalidomide combined with glucocorticoid in the treatment of refractory nephrotic syndrome
收藏切换
Li ZHANG1, Cuijuan FENG2, Tianyun HAN3
World Clinical Drug | 2022, 43(5) : 570 - 575
Less
收藏切换
World Clinical Drug | 2022, 43(5): 570-575
• Article •
Clinical observation of thalidomide combined with glucocorticoid in the treatment of refractory nephrotic syndrome
Full
Li ZHANG1, Cuijuan FENG2, Tianyun HAN3
Affiliations
  • 1.Chaoyang No.3 Retired Cadre Retreat of Beijing Garrison, Beijing 100101, China
  • 2.Department of Dermatology, the No. 2 Hospital of Baoding, Baoding 071000, Hebei Province, China
  • 3.Department of Pharmacy, the No. 2 Hospital of Baoding, Baoding 071000, Hebei Province, China
Published: 2022-05-10 doi: 10.13683/j.wph.2022.05.014
Outline
收藏切换
Objective

To explore the clinical efficacy of thalidomide combined with glucocorticoid in the treatment of refractory nephrotic syndrome.

Methods

Totally 120 patients with refractory nephrotic syndrome were randomly divided into control group (CG) and observation group (OG), according to random number table method, 60 cases in each group. CG were treated with glucocorticoid. OG were given thalidomide combined with glucocorticoid. The total remission rate, renal function indexes (serum creatinine, blood urea nitrogen and 24-hour urinary protein), serum albumin, clinical efficacy, incidence adverse reactions and quality of life scores were observed and compared between the two groups after treatment.

Results

There was no statistical significance in the two groups before treatment (P>0.05). After treatment, the total remission rate of OG was higher than that of CG (95.00% vs 78.33%, P<0.05). Compared with CG, serum creatinine, blood urea nitrogen and 24 h urinary protein of OG were decreased, while the serum albumin was increased (P<0.05). However, the incidence of adverse reactions of OG was higher than that of CG (33.33% vs 25.00%, P<0.05). The quality of life scores of OG was significantly higher than that of CG [(334.33±6.23) vs (291.11±6.94), P<0.05].

Conclusion

Thalidomide combined with glucocorticoid can effectively treat refractory nephrotic syndrome, improve the renal function of patients and quality of their life. However, the increased incidence of adverse reactions during and after treatment should be paid close attention.

thalidomide  /  glucocorticoid  /  prednisolone  /  refractory nephrotic syndrome
张莉, 冯翠娟, 韩天云. 沙利度胺联合糖皮质激素治疗难治性肾病综合征的临床疗效观察. 世界临床药物, 2022 , 43 (5) : 570 -575 . DOI: 10.13683/j.wph.2022.05.014
Li ZHANG, Cuijuan FENG, Tianyun HAN. Clinical observation of thalidomide combined with glucocorticoid in the treatment of refractory nephrotic syndrome[J]. World Clinical Drug, 2022 , 43 (5) : 570 -575 . DOI: 10.13683/j.wph.2022.05.014
Year 2022 volume 43 Issue 5
14
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.05.014
  • Receive Date:2021-10-28
  • Online Date:2026-11-19
  • Published:2022-05-10
Article Data
Affiliations
History
  • Received:2021-10-28
Funding
Affiliations
    1.Chaoyang No.3 Retired Cadre Retreat of Beijing Garrison, Beijing 100101, China
    2.Department of Dermatology, the No. 2 Hospital of Baoding, Baoding 071000, Hebei Province, China
    3.Department of Pharmacy, the No. 2 Hospital of Baoding, Baoding 071000, Hebei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.05.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT